Skip to main content

Table 7 Adverse events of DEB-TACE treatment

From: Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients

Parameters HCC Patients (N = 99)
During and post operation (<=24 h)
 Paina
  No paina (n/%) 4 (4.0)
  Light paina (n/%) 63 (63.6)
  Moderate paina (n/%) 30 (30.3)
  Severe paina (n/%) 2 (2.01)
 Vomitingb
  No vomitingb (n/%) 83 (83.8)
  Grade 1b (n/%) 13 (13.1)
  Grade 2b (n/%) 3 (3.0)
 Hypertension (n/%) 16 (16.2)
Post operation (24 h–72 h)
 Fever
  No fever (n/%) 23 (23.2)
  Low-grade fever (n/%) 36 (36.4)
  Median-grade fever (n/%) 31 (31.3)
  High-grade fever (n/%) 9 (9.1)
  1. Data was presented as count (%)
  2. Pain VAS Pain visual analogue scale
  3. aThe severity of pain was calculated by pain VAS: No pain: pain VAS score = 0; Light pain: pain VAS score = 1–3; Moderate pain: pain VAS score = 4–6; Severe pain: pain VAS score = 7–10. bGrade 1: times of vomiting =1–2; Grade 2: times of vomiting = 3–5